• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.10 Up 0.14(2.01%) 4:00PM EST
    |After Hours : 7.10 0.00 (0.00%) 4:26PM EST
    Add to Portfolio
    Prev Close:6.96
    Open:7.01
    Bid:6.91 x 100
    Ask:7.25 x 400
    1y Target Est:7.50
    Beta:0.63
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:6.99 - 7.15
    52wk Range:6.52 - 10.26
    Volume:7,785,961
    Avg Vol (3m):3,180,190
    Market Cap:1.16B
    P/E (ttm):3.82
    EPS (ttm):1.86
    Div & Yield:0.60 (8.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 2.01%1.16B
    AMGNUp 0.26%121.11B
    SGENUp 1.37%4.43B
    XOMADown 0.68%392.53M

    Key Statistics

    Forward P/E (1 yr):8.99
    P/S (ttm):2.32
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.20
    Quarterly EPS Est (Mar-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback